EMV Capital plc has announced its preliminary results for FY2024. The year saw a 67% revenue rise, with the company consolidating Martlet Capital into its operations, creating synergies across fund management. EMV Capital’s portfolio of investments also expanded to over 70 companies.
Other highlights include increasing Assets Under Management by 33% to £98.5 million, and reaching £103 million by May 2025. Multiple holdings in EMV Capital’s Venture Build practice are progressing to value inflection points, with significant increases in fair value. The company is also proud to have successfully launched its Fund Management practice.
Furthermore, capital has been managed efficiently using innovative balance sheet and share-based investments; and a £1.5 million placing was completed at a 15% premium to market price.
EMV Capital’s CEO Dr Ilian Iliev commented on outlook, noting that EMVC is “well positioned to withstand current macroeconomic headwinds and capitalise on a future market recovery, particularly as interest grows in several of the sectors in which we invest. The Directors believe that the next ‘cohort’ of outsized venture returns will come from companies in these sectors, driven by redirections of investment and M&A flows.
“Although the current climate for investment and exits remains difficult both in the UK and globally, we see meaningful opportunity amid the disruption. We remain cautious but are confident in our outlook, underpinned by a resilient investment model and operating platform. We have a differentiated strategy that allows us to unlock value from our existing portfolio and build our position further.
“Most encouragingly, several of our holdings are approaching inflection points, with the potential to deliver significant investment returns. Looking ahead, we believe the coming years will bring further momentum, growth, and strategic progress, cementing EMV Capital as a leading player in deep tech and life sciences, and delivering long-term value to our shareholders.”
Read more here.